Dr. Peter Block interviews presenter Dr. Eri Toda Kato regarding dapagliflozin on HF and mortality in diabetes based on EF (DECLARE TIMI-58). Visit http://www.acc.org/ACC19 for full meeting coverage. - Acute Coronary Syndromes - 51_5feba5631406a

DECLARE-TIMI 58 HFrEF | ACC.19

DECLARE-TIMI 58 HFrEF | ACC.19

13 Views
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:


Dr. Peter Block interviews presenter Dr. Eri Toda Kato regarding dapagliflozin on HF and mortality in diabetes based on EF (DECLARE TIMI-58). Visit http://www.acc.org/ACC19 for full meeting coverage.

Up Next Autoplay